Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes Mellitus
Clinical trial NCT02805361 · COMPLETED
Trial details
- NCT number
- NCT02805361
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-08-21
- Primary completion
- 2018-07-13
- Enrollment
- 511
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.